Medical Condition News

RSS

Updated results from Oncolytics Biotech's Phase II study of REOLYSIN presented at CTOS meeting

Oncolytics Biotech Inc. announced that a poster presentation covering updated results of a Phase II study of REOLYSIN(R) administered intravenously to patients with sarcomas metastatic to the lung will be presented at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting being held in Miami Beach, Florida on November 6th, 2009.

30 Oct 2009

Siemens Hearing Instruments introduces new hearing solutions at the ADA 2009 Convention

Siemens Hearing Instruments, Inc., (www.usa.siemens.com/hearing) one of the largest manufacturers of hearing instruments in the world, today announced several new product models and enhancements at SPLASH: The Academy of Doctors of Audiology's (ADA) 2009 Convention held October 29-31, 2009, in Clearwater, Florida.

30 Oct 2009

ASTRO to host news briefings on top cancer research papers

The American Society for Radiation Oncology (ASTRO) will host four news briefings with accompanying live webcasts on the top cancer research papers from its 51st Annual Meeting.

30 Oct 2009

Participation in clinical trials may offer better prognosis for patients with chronic heart failure

Patients with chronic heart failure who agree to take part in clinical trials have a better prognosis than those who do not, according to a study reported in the November European Journal of Heart Failure.

30 Oct 2009

Young medical school graduates more likely to recommend kidney transplantation for CKD patients

Compared with veteran doctors, recent medical school graduates are more likely to refer chronic kidney disease (CKD) patients for kidney transplantation before their patients require dialysis, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.

30 Oct 2009

GPC establishes grants to expand knowledge about probiotics

Today, the success of the Young Investigator Grant for Probiotics Research (YIGPRO) program was confirmed with the announcement of two $50,000 grants that are available to rising young investigators in the field of probiotics. 2010 marks the third consecutive year for the grants. The grants were established by The Global Probiotics Council (GPC), a committee formed by DANONE and Yakult Honsha Co., Ltd., and are designed to contribute to the advancement of probiotics and gastrointestinal microbiota research in the United States.

30 Oct 2009

Genetists identify gene signature expressed in skin associated with the occurrence of lung disease

At its most benign, the autoimmune disease scleroderma can discolor parts of the skin of its sufferers. At its most pernicious, it can thicken and harden their skin, their blood vessels, and their internal organs before, in many cases, killing them.

30 Oct 2009

Isotechnika Pharma develops portfolio of NICAMs with potent cyclophilin inhibition

Isotechnika Pharma Inc. today announced that it has developed a portfolio of non-immunosuppressive cyclosporine analogue molecules (NICAMs) with potent cyclophilin inhibition. Cyclophilin inhibition has garnered considerable attention as a novel therapy in the treatment of a wide range of diseases including hepatitis C, stroke, and chronic neurological disorders such as Parkinson's, Lou Gehrig's, and Alzheimer's.

30 Oct 2009

Clinical data on the validation set 'Alzheimer patients versus healthy controls' for AclarusDx presented

ExonHit Therapeutics yesterday presented clinical data on the validation set “Alzheimer patients versus healthy controls” for AclarusDx™ (formerly EHT Dx21), its blood-based diagnostic test for the detection of Alzheimer’s disease (AD), at the 2nd Conference of Clinical Trials on Alzheimer’s Disease (CTAD) in Las Vegas, USA.

30 Oct 2009

Current measurement of diabetes care quality is complex and cumbersome, says NCDP

The National Changing Diabetes® Program (NCDP) announced today results of a study that found extraordinary variety in the measurement of clinical processes critical to optimal diabetes management such as blood pressure and glucose levels.

30 Oct 2009

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.

30 Oct 2009

Studies demonstrate that investigational cancer vaccines show encouraging immune response rates

Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies.

30 Oct 2009

Smartphones for diabetic patients

Cellular phones - once a luxury used strictly for talking - have taken on many new roles in recent years. Now researchers at Saint Louis University and Old Dominion University in Virginia say smartphones can be used to help elderly diabetics manage their health and learn more about their condition.

30 Oct 2009

NeuroVigil and Roche collaborate to speed up drug development for CNS disorders

Today, leading California Neurotechnology company NeuroVigil and Swiss Pharma giant Roche announced an agreement regarding a major innovation in collecting and analyzing data from clinical trials.

30 Oct 2009

La Jolla Institute dedicates new Elam Discovery Wall and Type 1 Diabetes Center

The La Jolla Institute for Allergy & Immunology, an international leader in immunology research and San Diego's only research institute focused solely on immune-mediated diseases, today will dedicate its new Elam Discovery Wall and Type 1 Diabetes Center, which will focus on research into novel immunological-focused approaches to type 1 diabetes.

30 Oct 2009

UCSF scientists receive grants to advance stem cell based strategies for diabetes and brain tumors

Two teams of UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their stem cell based strategies for treating diabetes and brain tumors.

30 Oct 2009

New study reviews science behind the efficacy of biofield therapies on pain management

Biofield therapies, which claim to use subtle energy to stimulate the body's healing process, are promising complementary interventions for reducing the intensity of pain in a number of conditions, reducing anxiety for hospitalized patients and reducing agitated behaviors in dementia, over and above what standard treatments can achieve.

30 Oct 2009

Pre-dialysis recipients with high kidney function do not benefit from kidney transplants

Pre-dialysis transplant recipients with a high level of kidney function don't benefit from their transplant more than pre-dialysis recipients with low level kidney function, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.

30 Oct 2009

Winners of 4th annual Katz Prizes in Cardiovascular Research announced

Columbia University Medical Center today announces the winners of the 4th annual Katz Prizes in Cardiovascular Research, with the senior scientist prize being awarded to an internationally renowned researcher from the National Institutes of Health, and the young investigator prize recognizing a cardiovascular researcher actively studying left ventricular assist devices and heart function.

30 Oct 2009

Case Western Reserve awarded $14.7M to lead study on effects of lowering systolic blood pressure

Case Western Reserve University School of Medicine has received a $14.7 million, nine-year contract from the National Institutes of Health to be one of five institutions to lead a trial to determine if lowering systolic blood pressure in hypertensive patients, without diabetes, to below the currently recommended level can reduce the incidence of cardiovascular and kidney disease and slow cognitive decline.

30 Oct 2009

Medical Condition News

Updated results from Oncolytics Biotech's Phase II study of REOLYSIN presented at CTOS meeting

Siemens Hearing Instruments introduces new hearing solutions at the ADA 2009 Convention

ASTRO to host news briefings on top cancer research papers

Participation in clinical trials may offer better prognosis for patients with chronic heart failure

Young medical school graduates more likely to recommend kidney transplantation for CKD patients

GPC establishes grants to expand knowledge about probiotics

Genetists identify gene signature expressed in skin associated with the occurrence of lung disease

Isotechnika Pharma develops portfolio of NICAMs with potent cyclophilin inhibition

Clinical data on the validation set 'Alzheimer patients versus healthy controls' for AclarusDx presented

Current measurement of diabetes care quality is complex and cumbersome, says NCDP

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

Studies demonstrate that investigational cancer vaccines show encouraging immune response rates

Smartphones for diabetic patients

NeuroVigil and Roche collaborate to speed up drug development for CNS disorders

La Jolla Institute dedicates new Elam Discovery Wall and Type 1 Diabetes Center

UCSF scientists receive grants to advance stem cell based strategies for diabetes and brain tumors

New study reviews science behind the efficacy of biofield therapies on pain management

Pre-dialysis recipients with high kidney function do not benefit from kidney transplants

Winners of 4th annual Katz Prizes in Cardiovascular Research announced

Case Western Reserve awarded $14.7M to lead study on effects of lowering systolic blood pressure

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News